Publications : Team 4 / équipe 4

Publications : Team 4 / équipe 42018-07-09T16:40:26+00:00


Année 2018

(Liste des Publications par ordre alphabétique du premier auteur)

Les divers membres de l’équipe sont en gras


Ogier C, Colombo PE, Bousquet C, Canterel-Thouennon L, Sicard P, Garambois V, Thomas G, Gaborit N, Jarlier M, Pirot N, Pugnière M, Vie N, Gongora C, Martineau P, Robert B, Pèlegrin A, Chardès T, Larbouret C. (2018). Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer. Cancer Lett. 2018 Jun 20;432:227-236. (IF=6,49).


Année 2017


Akodad M, Fauconnier J, Sicard P, Huet , Blandel F, Bourret A, De Santa Barbara P, Aguilon S, Le Gall M, Hugon G, Lacampagne A, Roubille F. (2017). ” Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model. International Journal of Cardiology 2017 Aug 1;240:347-353. (IF=4,03).


Bourret A, Chauvet N, de Santa Barbara P, Faure S. 2017). “Colonic mesenchyme differentiates into smooth muscle before its colonization by vagal enteric neural crest-derived cells in the chick embryo.Cell Tissue Res. 2017 Jun;368(3):503-511 (IF=3,04).


Chauvet N, Romanò N, Lafont C, Guillou A, Galibert E, Bonnefont X, Le Tissier P, Fedele M, Fusco A, Mollard P, Coutry N. (2017). “Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse model.Int J Cancer. 2017 May 1;140(9):2150-2161. (IF=7,36).


Année 2016



Chauvet N, Romanò N, Meunier AC, Galibert E, Fontanaud P, Mathieu MN, Osterstock G, Osterstock P, Baccino E, Rigau V, Loiseau H, Bouillot-Eimer S, Barlier A, Mollard P, Coutry N. (2016). ““Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas.J Neuroendocrinol. 2016 Feb;28(2):12352. (IF=3,47).


McKey J, Martire D, de Santa Barbara P, Faure S.  (2016). “LIX1 regulates YAP1 activity and controls the proliferation and differentiation of stomach mesenchymal progenitors.BMC Biol. 2016 Apr 28;14(1):34. (IF =6,78).


Ohayon D, Garcès A, Joly W, Soukkarieh C, Takagi T, Sabourin JC, Agius E, Darling DS, De Santa Barbara P, Higashi Y, Stolt CC, Hugnot JP, Richardson WD, Carroll P, Pattyn A. (2016). “Onset of Spinal Cord Astrocyte Precursor Emigration from the Ventricular Zone Involves the Zeb1 Transcription Factor.Cell Rep. 2016 Nov 1;17(6):1473-1481. (IF=8,28).


Sagnol S, Marchal S, Yang Y, Allemand F, de Santa Barbara P. (2016). “Epithelial Splicing Regulatory Protein 1 (ESRP1) is a new regulator of stomach smooth muscle development and plasticity.Dev Biol. 2016 Jun 15;414(2):207-18 (IF=2,94).


Année 2015



Coxam B, Neyt C, Grassini DR, Le Guen L, Smith KA, Schulte-Merker S, Hogan BM. (2015).”Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (cad) regulates Notch signaling and vascular development in zebrafish.Dev Dyn. 244(1):1-9 (IF= 2.23).


Deleyrolle L, Sabourin JC, Rothhut B, Fujita H, Guichet PO, Teigell M, Ripoll C, Chauvet N, Perrin F, Mamaeva D, Noda T, Mori K, Yoshihara Y, Hugnot JP. (2015). “OCAM regulates embryonic spinal cord stem cell proliferation by modulating ErbB2 receptor.PLoS One.10(4):e0122337.(IF=3,06).


Faure S, Fort P. (2015). “Atypical RhoV and RhoU GTPases control development of the neural crest.Small GTPases. 2015 Oct 2;6(4):174-7


Faure S, McKey J, Sagnol S, de Santa Barbara P. (2015). “ Enteric neural crest cells regulate vertebrate stomach patterning and differentiation.Development. 142(2):331-42. (IF= 6.06).


Le Guen L, Marchal S, Faure S, de Santa Barbara P. (2015). “ Mesenchymal-epithelial interactions during digestive tract development and epithelial stem cell regeneration. “  Cell Mol Life Sci. 72(20):3883-96. (IF=5,69).


Année 2014


  • Chetaille P, Preuss C, Burkhard S, Côté JM, Houde C, Castilloux J, Piché J, Gosset N, Leclerc S, Wünnemann F, Thibeault M, Gagnon C, Galli A, Tuck E, Hickson GR, Amine NE, Boufaied I, Lemyre E, de Santa Barbara P, Faure S, Jonzon A, Cameron M, Dietz HC, Gallo-McFarlane E, Benson DW, Moreau C, Labuda D; FORGE Canada Consortium, Zhan SH, Shen Y, Jomphe M, Jones SJ, Bakkers J, Andelfinger G. (2014).”Mutations in SGOL1 cause a novel cohesinopathy affecting heart and gut rhythm.Nat Genet. 46(11):1245-9. (IF=29.65).